129 related articles for article (PubMed ID: 3604394)
1. Liposomes as immunological adjuvants: antigen incorporation studies.
Gregoriadis G; Davis D; Davies A
Vaccine; 1987 Jun; 5(2):145-51. PubMed ID: 3604394
[TBL] [Abstract][Full Text] [Related]
2. Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics.
Davis D; Gregoriadis G
Immunology; 1987 Jun; 61(2):229-34. PubMed ID: 3596639
[TBL] [Abstract][Full Text] [Related]
3. A novel positively-charged lipid 1,2-bis(hexadecylcycloxy)-3-trimethyl aminopropane (BisHOP) enhances the adjuvant effect of liposomes on encapsulated tetanus toxoid.
Tan L; Gregoriadis G
Asian Pac J Allergy Immunol; 1991 Jun; 9(1):21-4. PubMed ID: 1776976
[TBL] [Abstract][Full Text] [Related]
4. Liposomes as vaccine carriers. Incorporation of soluble and particulate antigens in giant vesicles.
Antimisiaris SG; Jayasekera P; Gregoriadis G
J Immunol Methods; 1993 Dec; 166(2):271-80. PubMed ID: 8288880
[TBL] [Abstract][Full Text] [Related]
5. Liposomes as adjuvants with immunopurified tetanus toxoid: the immune response.
Davis D; Davies A; Gregoriadis G
Immunol Lett; 1987 Apr; 14(4):341-8. PubMed ID: 3583325
[TBL] [Abstract][Full Text] [Related]
6. Primary immune response to liposomal tetanus toxoid in mice: the effect of mediators.
Davis D; Gregoriadis G
Immunology; 1989 Oct; 68(2):277-82. PubMed ID: 2509329
[TBL] [Abstract][Full Text] [Related]
7. Immunoadjuvant action of liposomes: comparison with other adjuvants.
Gregoriadis G; Panagiotidi C
Immunol Lett; 1989 Feb; 20(3):237-40. PubMed ID: 2714847
[TBL] [Abstract][Full Text] [Related]
8. Coupling of ligands to liposomes independently of solute entrapment: observations on the formed vesicles.
Gregoriadis G; Garcon N; da Silva H; Sternberg B
Biochim Biophys Acta; 1993 Apr; 1147(2):185-93. PubMed ID: 8476912
[TBL] [Abstract][Full Text] [Related]
9. Liposome-mediated DNA vaccination: the effect of vesicle composition.
Perrie Y; Frederik PM; Gregoriadis G
Vaccine; 2001 Apr; 19(23-24):3301-10. PubMed ID: 11312029
[TBL] [Abstract][Full Text] [Related]
10. Mannose-mediated targeted immunoadjuvant action of liposomes.
Garcon N; Gregoriadis G; Taylor M; Summerfield J
Immunology; 1988 Aug; 64(4):743-5. PubMed ID: 3169846
[TBL] [Abstract][Full Text] [Related]
11. The immunological co-adjuvant action of liposomal interleukin-2: the role of mode of localisation of the cytokine and antigen in the vesicles.
Gursel M; Gregoriadis G
J Drug Target; 1998; 5(2):93-8. PubMed ID: 9588865
[TBL] [Abstract][Full Text] [Related]
12. Liposome-mediated DNA immunisation via the subcutaneous route.
Perrie Y; McNeil S; Vangala A
J Drug Target; 2003; 11(8-10):555-63. PubMed ID: 15203925
[TBL] [Abstract][Full Text] [Related]
13. Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen.
Gregoriadis G; Tan L; Ben-Ahmeida ET; Jennings R
Vaccine; 1992; 10(11):747-53. PubMed ID: 1441730
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-15 acts as an immunological co-adjuvant for liposomal antigen in vivo.
Gursel M; Gregoriadis G
Immunol Lett; 1997 Mar; 55(3):161-5. PubMed ID: 9161882
[TBL] [Abstract][Full Text] [Related]
15. Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.
Kahl LP; Scott CA; Lelchuk R; Gregoriadis G; Liew FY
J Immunol; 1989 Jun; 142(12):4441-9. PubMed ID: 2786033
[TBL] [Abstract][Full Text] [Related]
16. Humoral immune response against epidermal growth factor encapsulated in dehydration rehydration vesicles of different phospholipid composition.
Lanio ME; Luzardo MC; Alvarez C; Martínez Y; Calderón L; Alonso ME; Zadi B; Gregoriadis G; Craig DQ; Disalvo A
J Liposome Res; 2008; 18(1):1-19. PubMed ID: 18348068
[TBL] [Abstract][Full Text] [Related]
17. Liposome (Lipodine)-mediated DNA vaccination by the oral route.
Perrie Y; Obrenovic M; McCarthy D; Gregoriadis G
J Liposome Res; 2002; 12(1-2):185-97. PubMed ID: 12604053
[TBL] [Abstract][Full Text] [Related]
18. The effect of microfluidization of protein-coated liposomes on protein distribution on the surface of generated small vesicles.
Skalko N; Bouwstra J; Spies F; Gregoriadis G
Biochim Biophys Acta; 1996 Jun; 1301(3):249-54. PubMed ID: 8664336
[TBL] [Abstract][Full Text] [Related]
19. Immunoactivating potential of multilamellar liposome vesicles (MLV) in murine popliteal lymph node (PLN) test.
Desjardins R; Krzystyniak K; Thérien HM; Banska W; Tancrede P; Fournier M
Int J Immunopharmacol; 1995 May; 17(5):367-74. PubMed ID: 7591360
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Leishmania major antigen-liposomes that protect BALB/c mice against cutaneous leishmaniasis.
Kahl LP; Lelchuk R; Scott CA; Beesley J
Infect Immun; 1990 Oct; 58(10):3233-41. PubMed ID: 2401562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
